The global electrophoresis market revenue was around US$ 2.4 billion in 2022 and is estimated to reach US$ 3.95 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period from 2023 to 2031.
Electrophoresis is a technique used for the separation of nucleic acids and proteins. Electrophoresis equipment and supplies are mainly used for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) analysis. It is also utilized in biochemistry for the separation of molecules based on affinity, size, or charge. The protein separation based on purity, size, and density is carried out utilizing electrophoresis.
Market Driving Factors
Increasing industry-academia research collaborations is expected to drive the market. This is due to the electrophoresis technology plays a key role in promoting groundbreaking discoveries as academic and research institutes delve deeper into proteomics, genomics, and molecular biology. As a result, collaborative initiatives, presented by collaborations between key players and educational institutions, contribute to boosting awareness and skill development among researchers and students. These synergies encourage innovation and the adoption of cutting-edge electrophoresis technologies.
Surging demand for personalized medicines is estimated to create opportunities in the market. This is mainly due to personalized medicine, which has evolved as a core area of research in the healthcare industry, has entered mainstream clinical practice, and is altering how many diseases are classified, identified, and treated. In addition, these advancements are especially evident in the oncology area. This increasing demand for personalized medicine is estimated to surge in the uptake of electrophoretic systems in the drug development procedure.
The requirement for high procedural efficiency to ensure proper results is estimated to hamper the market.
Regional Analysis
North America dominated the market in terms of the largest shares and is expected to maintain its dominance. This can be primarily attributed to many factors such as the surge in government funds for the detection of new proteins, the rise in R&D activities of new drugs for treatment and diagnosis options, and growth in the prevalence of chronic diseases such as diabetes and cancer.
Asia-Pacific is estimated to dominate the market in terms of the growth rate. This is mainly owing to the surge in per capita income in various nations, the increase in government initiatives for the enhancement of the healthcare sector, and the rise in the emphasis of leading manufacturers on augmenting their geographic existence in emerging nations in the region.
Segmentation Insights
Product Insight
The electrophoresis reagents segment dominates the market in terms of the highest shares during the projection period. This is mainly due to many factors such as a surge in funding for proteomic and genomic research, an increase in the prevalence of chronic conditions, a rise in partnerships between industry and academics, and technological developments.
Application Insight
The diagnostic segment is predicted to dominate the market in terms of the largest shares. This is mainly due to various factors such as the increasing demand for efficient and accurate diagnostic methods in healthcare environments, the rising prevalence of metabolic and genetic disorders needing effective diagnostic tools, and the immediate adoption of electrophoresis techniques for hemoglobinopathies and protein analyses.
End User Insight
The pharmaceutical and biotechnology companies segment dominated the market in terms of the growth rate and is expected to continue its dominance. This can be majorly attributed to the increased penetration of electrophoresis in pharmaceutical & biotechnology companies, for DNA analysis, protein detection, antibodies testing, and DNA fragmentation.
The research organizations segment is estimated to dominate the market in terms of revenue. This is owing to the surge in the adoption of electrophoresis provides significant benefits for research organizations such as it is slightly time-consuming, has minor reagents requirements, and a minimal quantity of sample is needed.
Prominent Companies
Segmentation Outline
The global electrophoresis market segmentation focuses on the Product, Application, End User, and Region.
By Product
By Application
By End User
By Region
[TABLE OF CONTENTS]
1 INTRODUCTION OF GLOBAL ELECTROPHORESIS MARKET
1.1 OVERVIEW OF THE MARKET
1.2 SCOPE OF REPORT
1.3 ASSUMPTIONS
2 EXECUTIVE SUMMARY: ELECTROPHORESIS MARKET
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 VALIDATION
3.3 PRIMARY INTERVIEWS
3.4 LIST OF DATA SOURCES
3.5 ANALYST TOOLS AND MODELS
4 GLOBAL ELECTROPHORESIS MARKET OUTLOOK
4.1 OVERVIEW
4.2 MARKET DYNAMICS AND TRENDS
4.2.1 DRIVERS
4.2.2 RESTRAINTS
4.2.3 OPPORTUNITIES
4.3 PORTERS FIVE FORCE ANALYSIS
4.4 VALUE CHAIN ANALYSIS
4.5 MARKET GROWTH AND OUTLOOK
4.5.1 PRICE TREND ANALYSIS
4.5.2 OPPORTUNITY SHARE
5 GLOBAL ELECTROPHORESIS MARKET, BY PRODUCT
5.1 OVERVIEW
5.2 ELECTROPHORESIS SYSTEMS
5.2.1 GEL ELECTROPHORESIS SYSTEMS
5.2.2 CAPILLARY ELECTROPHORESIS SYSTEMS
5.3 GEL DOCUMENTATION SYSTEMS AND SOFTWARES
5.4 ELECTROPHORESIS REAGENTS
5.4.1 PROTEIN ELECTROPHORESIS REAGENTS
5.4.2 NUCLEIC ACID ELECTROPHORESIS REAGENTS
6 GLOBAL ELECTROPHORESIS MARKET, BY APPLICATION
6.1 OVERVIEW
6.2 DIAGNOSTIC
6.3 RESEARCH
6.4 QUALITY CONTROL AND PROCESS VALIDATION
7 GLOBAL ELECTROPHORESIS MARKET, BY END USER
7.1 OVERVIEW
7.2 ACADEMIC INSTITUTIONS
7.3 HOSPITALS AND DIAGNOSTIC CENTERS
7.4 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
7.5 RESEARCH ORGANIZATIONS
8 GLOBAL ELECTROPHORESIS MARKET, BY GEOGRAPHY
8.1 OVERVIEW
8.2 NORTH AMERICA
8.2.1 NORTH AMERICA MARKET SNAPSHOT
8.2.2 U.S.
8.2.3 CANADA
8.2.4 MEXICO
8.3 EUROPE
8.3.1 EUROPE MARKET SNAPSHOT
8.3.2 WESTERN EUROPE
8.3.2.1 THE UK
8.3.2.2 GERMANY
8.3.2.3 FRANCE
8.3.2.4 ITALY
8.3.2.5 SPAIN
8.3.2.6 REST OF WESTERN EUROPE
8.3.3 EASTERN EUROPE
8.3.3.1 POLAND
8.3.3.2 RUSSIA
8.3.3.3 REST OF EASTERN EUROPE
8.4 ASIA PACIFIC
8.4.1 ASIA PACIFIC MARKET SNAPSHOT
8.4.2 CHINA
8.4.3 JAPAN
8.4.4 INDIA
8.4.5 AUSTRALIA & NEW ZEALAND
8.4.6 ASEAN
8.4.7 REST OF ASIA PACIFIC
8.5 MIDDLE EAST & AFRICA
8.5.1 MIDDLE EAST & AFRICA MARKET SNAPSHOT
8.5.2 UAE
8.5.3 SAUDI ARABIA
8.5.4 SOUTH AFRICA
8.5.5 REST OF MEA
8.6 SOUTH AMERICA
8.6.1 SOUTH AMERICA MARKET SNAPSHOT
8.6.2 BRAZIL
8.6.3 ARGENTINA
8.6.4 REST OF SOUTH AMERICA
9 GLOBAL ELECTROPHORESIS MARKET COMPETITIVE LANDSCAPE
9.1 OVERVIEW
9.2 COMPANY MARKET RANKING
9.3 KEY DEVELOPMENT STRATEGIES
9.4 COMPETITIVE DASHBOARD
9.5 PRODUCT MAPPING
9.6 TOP PLAYER POSITIONING, 2022
9.7 COMPETITIVE HEATMAP
9.8 TOP WINNING STRATEGIES
10 COMPANY PROFILES
10.1 THERMO FISHER SCIENTIFIC
10.1.1 OVERVIEW
10.1.2 FINANCIAL PERFORMANCE
10.1.3 PRODUCT OUTLOOK
10.1.4 KEY DEVELOPMENTS
10.1.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.2 SCHIMADZU
10.2.1 OVERVIEW
10.2.2 FINANCIAL PERFORMANCE
10.2.3 PRODUCT OUTLOOK
10.2.4 KEY DEVELOPMENTS
10.2.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.3 QIAGEN NV
10.3.1 OVERVIEW
10.3.2 FINANCIAL PERFORMANCE
10.3.3 PRODUCT OUTLOOK
10.3.4 KEY DEVELOPMENTS
10.3.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.4 MERCK & CO. INC
10.4.1 OVERVIEW
10.4.2 FINANCIAL PERFORMANCE
10.4.3 PRODUCT OUTLOOK
10.4.4 KEY DEVELOPMENTS
10.4.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.5 HARVARD
10.5.1 OVERVIEW
10.5.2 FINANCIAL PERFORMANCE
10.5.3 PRODUCT OUTLOOK
10.5.4 KEY DEVELOPMENTS
10.5.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.6 AGILENT
10.6.1 OVERVIEW
10.6.2 FINANCIAL PERFORMANCE
10.6.3 PRODUCT OUTLOOK
10.6.4 KEY DEVELOPMENTS
10.6.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.7 PERKINELMER
10.7.1 OVERVIEW
10.7.2 FINANCIAL PERFORMANCE
10.7.3 PRODUCT OUTLOOK
10.7.4 KEY DEVELOPMENTS
10.7.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.8 DANAHER
10.8.1 OVERVIEW
10.8.2 FINANCIAL PERFORMANCE
10.8.3 PRODUCT OUTLOOK
10.8.4 KEY DEVELOPMENTS
10.8.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.9 BIO-RAD CORPORATION
10.9.1 OVERVIEW
10.9.2 FINANCIAL PERFORMANCE
10.9.3 PRODUCT OUTLOOK
10.9.4 KEY DEVELOPMENTS
10.9.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
10.10 LONZA GROUP
10.10.1 OVERVIEW
10.10.2 FINANCIAL PERFORMANCE
10.10.3 PRODUCT OUTLOOK
10.10.4 KEY DEVELOPMENTS
10.10.5 KEY STRATEGIC MOVES AND DEVELOPMENTS
01
お客様のニーズに合わせてレポートをカスタマイズ可能
02
ベテランの市場調査員による専門的な分析
03
安全で簡単に利用できるオンライン決済方法
04
お客様のご要望に応じて、特定の章を購入することができます。
05
すべてのレポートに専門的な日本語翻訳を提供
06
包括的でわかりやすいレポートを迅速にお届けします。
07
購入後も継続的なサポートとアップデートが受けられます。
We Accept
Copyright ©2022 All rights reserved